Immediate Impact
53 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Prunin: An Emerging Anticancer Flavonoid
2025 Standout
Works of Xufeng Chen being referenced
Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC
2019
Epidermal growth factor receptor ( EGFR ) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non‐small cell lung cancer progression during first‐generation tyrosine kinase inhibitor therapy: a prospective observational study
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xufeng Chen | 367 | 259 | 214 | 228 | 31 | 689 | |
| Hao Feng | 393 | 184 | 101 | 249 | 35 | 643 | |
| Milena Rondón‐Lagos | 318 | 154 | 179 | 229 | 37 | 683 | |
| Sabrina Vari | 425 | 183 | 264 | 193 | 30 | 776 | |
| Qingyang Gu | 341 | 111 | 228 | 148 | 26 | 636 | |
| Li Yan | 387 | 173 | 328 | 201 | 51 | 842 | |
| Yingying Liang | 418 | 183 | 333 | 249 | 27 | 833 | |
| Yikun Li | 516 | 207 | 219 | 78 | 28 | 809 | |
| Ting Liu | 350 | 317 | 332 | 159 | 24 | 753 | |
| Wan-Ju Kim | 551 | 108 | 266 | 209 | 25 | 801 | |
| Alessandro Perez | 293 | 201 | 264 | 179 | 41 | 670 |
All Works
Login with ORCID to disown or claim papers
Loading papers...